- Report
- May 2025
- 267 Pages
Global
From €4358EUR$4,950USD£3,766GBP
- Report
- January 2026
- 185 Pages
Global
From €3962EUR$4,500USD£3,424GBP
- Report
- January 2026
- 198 Pages
Global
From €3121EUR$3,545USD£2,697GBP
€3468EUR$3,939USD£2,997GBP
- Report
- May 2026
- 220 Pages
Global
From €5150EUR$5,850USD£4,451GBP
- Report
- February 2026
- 250 Pages
Global
From €3953EUR$4,490USD£3,416GBP
- Report
- August 2025
- 147 Pages
Global
From €3477EUR$3,950USD£3,005GBP
- Report
- January 2026
- 160 Pages
Global
From €2956EUR$3,358USD£2,555GBP
€3477EUR$3,950USD£3,005GBP
- Report
- May 2026
- 421 Pages
Global
From €6158EUR$6,995USD£5,322GBP
- Report
- November 2025
- 150 Pages
Global
From €5238EUR$5,950USD£4,527GBP
- Report
- May 2025
- 100 Pages
Global
From €5238EUR$5,950USD£4,527GBP
- Report
- January 2026
- 180 Pages
Global
From €3962EUR$4,500USD£3,424GBP
- Report
- June 2025
- 182 Pages
Global
From €3962EUR$4,500USD£3,424GBP
- Report
- January 2026
- 180 Pages
Global
From €3121EUR$3,545USD£2,697GBP
€3468EUR$3,939USD£2,997GBP
- Report
- May 2026
- 282 Pages
Global
From €5150EUR$5,850USD£4,451GBP
- Report
- May 2026
- 174 Pages
Global
From €5150EUR$5,850USD£4,451GBP
- Report
- March 2026
- 250 Pages
Global
From €3953EUR$4,490USD£3,416GBP
- Report
- March 2026
- 250 Pages
Global
From €3953EUR$4,490USD£3,416GBP
- Report
- February 2026
- 250 Pages
Global
From €3953EUR$4,490USD£3,416GBP
- Report
- February 2026
- 250 Pages
Global
From €3953EUR$4,490USD£3,416GBP
- Report
- November 2025
- 250 Pages
Global
From €3517EUR$3,995USD£3,040GBP

The CRISPR market is a subset of the genomics market that focuses on the use of CRISPR-Cas9 technology for gene editing. CRISPR-Cas9 is a powerful tool that enables scientists to make precise changes to the genome of living organisms. This technology has been used to develop treatments for a variety of diseases, as well as to create new crops and livestock. CRISPR-Cas9 technology has also been used to create gene drives, which are designed to spread a desired trait through a population.
The CRISPR market is highly competitive, with a number of companies offering products and services related to gene editing. These companies include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, Caribou Biosciences, and ERS Genomics. These companies are developing a range of products, from gene editing tools to gene therapies, and are working to make CRISPR-Cas9 technology more accessible and affordable. Show Less Read more